A nurse is reinforcing teaching with the family of a client who has a new prescription for donepezil.
Which of the following therapeutic effects should the nurse inform the family to expect?
Decreased urinary output.
Improved pulmonary function.
Improved cognitive function.
Decreased incidence of seizures.
The Correct Answer is C
Choice A rationale:
Donepezil does not decrease urinary output. It works by increasing the amount of a certain naturally occurring substance in the brain.
Choice B rationale:
Donepezil does not improve pulmonary function. Its primary function is to improve mental function.
Choice C rationale:
Donepezil improves cognitive function. It can improve thinking ability and slow the loss of these abilities in people who have Alzheimer’s disease.
Choice D rationale:
Donepezil does not decrease the incidence of seizures. In fact, patients should inform their healthcare provider if they have a history of seizures before starting donepezil.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A rationale:
Docusate sodium is a stool softener and does not have a direct effect on blood pressure. It is generally safe for individuals with hypertension.
Choice B rationale:
Pseudoephedrine is a decongestant that can raise blood pressure or interfere with the effectiveness of some prescribed blood pressure medications. Therefore, it is contraindicated for clients with hypertension.
Choice C rationale:
Omeprazole is a proton pump inhibitor used to decrease stomach acid. It does not have a significant impact on blood pressure and is generally safe for individuals with hypertension.
Choice D rationale:
Guaifenesin is an expectorant used to thin mucus in the air passages. It does not have a significant impact on blood pressure and is generally safe for individuals with hypertension.
Correct Answer is D
Explanation
Choice A rationale:
Montelukast does not improve peripheral vasodilation. It is a leukotriene receptor antagonist used to reduce inflammation in the airways.
Choice B rationale:
Montelukast does not increase the WBC count. It works by reducing inflammation in the airways, not by affecting the immune system.
Choice C rationale:
Montelukast does not neutralize gastric acid. It is not an antacid or proton pump inhibitor, it is used to reduce inflammation in the airways.
Choice D rationale:
Montelukast reduces bronchial inflammation. It helps to prevent asthma attacks and exercise-induced bronchoconstriction by reducing inflammation in the airways.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.